Otsuka Holdings Co., Ltd. Stock – Fundamental Analysis

Price
11,480.00
10/14/2026
Dec 2010
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 5/19/2026)

Balance Sheet Total Assets 4,197,562,000,000.00 ROE 72.27 %
Balance Sheet Total Equity 3,099,761,000,000.00 ROA 8.65 %
Cashflow Capital Expenditures -87,841,000,000.00 P/FCF 19.17
Cashflow Free Cash Flow 315,738,000,000.00 – –
Cashflow Operating Cash Flow 403,579,000,000.00 P/CF 14.99
Income Earnings per Share (diluted) 685.06 Div. Yield 1.22 %
Income Net Income 363,150,000,000.00 P/E 16.76
Income Shares Outstanding 527,115,000.00 P/B 1.99
Income Total Revenue 2,468,892,000,000.00 P/S 2.45

Ratios calculated on: 10/14/2026

Company Description

Otsuka Holdings Co., Ltd. is a Japan-based pharmaceutical holding company engaged in four business segments. The Medical-related segment is engaged in the sale of ethical drugs, the manufacture, sale and export of curative medicines, as well as the research and development of infusions. The Nutraceuticals-related segment is engaged in the manufacture, purchase and sale of nutraceuticals-related products, such as functional foods and dietary supplements. The Consumer-related segment is engaged in the manufacture and sale of consumer products and mineral water. The Others segment is engaged in the manufacture and sale of chemical products, the manufacture, sale and import of measuring equipment, the manufacture of packaging products, the manufacture of synthetic resin molding products, as well as the storage and handling of its products. As of March 31, 2014, the Company had 131 subsidiaries and 34 associated companies.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.otsuka.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more